Matches in SemOpenAlex for { <https://semopenalex.org/work/W3187029335> ?p ?o ?g. }
- W3187029335 endingPage "105174" @default.
- W3187029335 startingPage "105174" @default.
- W3187029335 abstract "Novel non-camptothecin (non-CPT) class of conformationally constrained, hitherto unknown 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives have been designed, synthesized and evaluated for anti-cancer activity. In vitro anti-proliferation evaluation against human cancer cell lines (A549 and MCF-7) exhibited significant cytotoxicity. Among the derivatives (8-24), 8 (IC50 0.44 μM and IC50 0.62 μM) and 12 (IC50 0.69 μM and IC50 0.54 μM) were identified as the most promising candidate against A-549 and MCF-7 cancer cell lines respectively. Topo I inhibitory activity of 8 and 12 suggested that, they may be developed as potential anti-cancer molecules in future and rationalized by docking analysis with effective binding modes. Further, in silico ADME prediction studies of all derivatives were found promising, signifying the drug like properties. In precise, the present investigation displays a new strategy to synthesize and emphasis on anticancer activities of conformationally constrained dibenzo[b,h][1,6] naphthyridine derivatives and Chromeno[3,2-c] quinoline derivatives in the context of cancer drug development and refinement." @default.
- W3187029335 created "2021-08-02" @default.
- W3187029335 creator A5006049508 @default.
- W3187029335 creator A5010213491 @default.
- W3187029335 creator A5014345790 @default.
- W3187029335 creator A5037139434 @default.
- W3187029335 creator A5059172235 @default.
- W3187029335 creator A5069038083 @default.
- W3187029335 creator A5085409490 @default.
- W3187029335 creator A5086638792 @default.
- W3187029335 creator A5090542131 @default.
- W3187029335 date "2021-10-01" @default.
- W3187029335 modified "2023-10-18" @default.
- W3187029335 title "Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions" @default.
- W3187029335 cites W1968904517 @default.
- W3187029335 cites W1970890275 @default.
- W3187029335 cites W1972246768 @default.
- W3187029335 cites W1986303714 @default.
- W3187029335 cites W1988124545 @default.
- W3187029335 cites W1988695114 @default.
- W3187029335 cites W1997812288 @default.
- W3187029335 cites W2001570602 @default.
- W3187029335 cites W2006779336 @default.
- W3187029335 cites W2008110748 @default.
- W3187029335 cites W2012312315 @default.
- W3187029335 cites W2026281627 @default.
- W3187029335 cites W2032441027 @default.
- W3187029335 cites W2034111853 @default.
- W3187029335 cites W2035234040 @default.
- W3187029335 cites W2035602318 @default.
- W3187029335 cites W2068577449 @default.
- W3187029335 cites W2069924034 @default.
- W3187029335 cites W2077054904 @default.
- W3187029335 cites W2078388638 @default.
- W3187029335 cites W2086230884 @default.
- W3187029335 cites W2089937596 @default.
- W3187029335 cites W2094747148 @default.
- W3187029335 cites W2115354062 @default.
- W3187029335 cites W2118642576 @default.
- W3187029335 cites W2123374199 @default.
- W3187029335 cites W2124021652 @default.
- W3187029335 cites W2124624490 @default.
- W3187029335 cites W2128781208 @default.
- W3187029335 cites W2132600317 @default.
- W3187029335 cites W2146274229 @default.
- W3187029335 cites W2154312495 @default.
- W3187029335 cites W2158368342 @default.
- W3187029335 cites W2160891250 @default.
- W3187029335 cites W2172099186 @default.
- W3187029335 cites W2390517379 @default.
- W3187029335 cites W2411740509 @default.
- W3187029335 cites W2473922752 @default.
- W3187029335 cites W2497200850 @default.
- W3187029335 cites W2507958286 @default.
- W3187029335 cites W2552689420 @default.
- W3187029335 cites W2605474943 @default.
- W3187029335 cites W2605478093 @default.
- W3187029335 cites W2620590125 @default.
- W3187029335 cites W2626252405 @default.
- W3187029335 cites W2735280882 @default.
- W3187029335 cites W2766399777 @default.
- W3187029335 cites W2793744664 @default.
- W3187029335 cites W2802776187 @default.
- W3187029335 cites W2897423284 @default.
- W3187029335 cites W2924356911 @default.
- W3187029335 cites W2934347186 @default.
- W3187029335 cites W2943185265 @default.
- W3187029335 cites W2964241842 @default.
- W3187029335 cites W2979178778 @default.
- W3187029335 cites W300253233 @default.
- W3187029335 cites W3009223186 @default.
- W3187029335 cites W3014152605 @default.
- W3187029335 cites W3015765425 @default.
- W3187029335 cites W3033033440 @default.
- W3187029335 cites W4236530034 @default.
- W3187029335 cites W618564271 @default.
- W3187029335 cites W982092013 @default.
- W3187029335 doi "https://doi.org/10.1016/j.bioorg.2021.105174" @default.
- W3187029335 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34314913" @default.
- W3187029335 hasPublicationYear "2021" @default.
- W3187029335 type Work @default.
- W3187029335 sameAs 3187029335 @default.
- W3187029335 citedByCount "15" @default.
- W3187029335 countsByYear W31870293352021 @default.
- W3187029335 countsByYear W31870293352022 @default.
- W3187029335 countsByYear W31870293352023 @default.
- W3187029335 crossrefType "journal-article" @default.
- W3187029335 hasAuthorship W3187029335A5006049508 @default.
- W3187029335 hasAuthorship W3187029335A5010213491 @default.
- W3187029335 hasAuthorship W3187029335A5014345790 @default.
- W3187029335 hasAuthorship W3187029335A5037139434 @default.
- W3187029335 hasAuthorship W3187029335A5059172235 @default.
- W3187029335 hasAuthorship W3187029335A5069038083 @default.
- W3187029335 hasAuthorship W3187029335A5085409490 @default.
- W3187029335 hasAuthorship W3187029335A5086638792 @default.
- W3187029335 hasAuthorship W3187029335A5090542131 @default.
- W3187029335 hasConcept C104317684 @default.
- W3187029335 hasConcept C109316439 @default.